Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2008
12/17/2008CN101326183A Bicyclic heterocyclic compounds as antiinflammatory agents
12/17/2008CN101326182A 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
12/17/2008CN101326181A Imidazopyridine derivatives as a2b adenosine receptor antagonists
12/17/2008CN101326162A Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
12/17/2008CN101325954A Quinazolinone derivatives as vanilloid antagonists
12/17/2008CN101323782A Perylene electroluminescent material with hole-transporting material and preparation thereof
12/17/2008CN101323609A Method for synthesizing high antipode content benzimidazole derivative by unsymmetrical oxidizing thioether into sulphoxide
12/17/2008CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465836 Hydrolytically-resistant boron-containing therapeutics and methods of use
12/16/2008US7465798 Methods and compositions for selectin inhibition
12/16/2008US7465743 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
12/16/2008US7465740 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
12/16/2008US7465739 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes
12/16/2008US7465726 Substituted pyrrolo[2.3-B]pyridines
12/16/2008US7465722 Biphenyl vasopressin agonists
12/16/2008US7465437 Delivery of anti-migraine compounds through an inhalation route
12/16/2008US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products
12/16/2008US7465435 Delivery of beta-blockers through an inhalation route
12/16/2008CA2302937C Method for producing (hetero)aromatic hydroxylamines
12/16/2008CA2285817C Novel basic derivatives of benz[e]isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-ht3-antagonistic activity, their preparation and their therapeutic use
12/11/2008WO2008150799A1 Imidazopyridine kinase inhibitors
12/11/2008WO2008150260A1 8-oxy-2-aminopyrido (2, 3-d) pyrimidin-7-one derivatives as kinase inhibitors and anticancer agents
12/11/2008WO2008150015A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008WO2008149168A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
12/11/2008WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor
12/11/2008WO2008148832A1 Compounds which potentiate ampa receptor and uses therof in medicine
12/11/2008WO2008148617A1 Beta-carboline arylsulfonamides, method for preparing them and composition comprising them
12/11/2008WO2008148560A1 New hybrid compounds of nucleobases and organic redox molecules and their use
12/11/2008WO2008123800A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles
12/11/2008WO2008116815A3 Compounds
12/11/2008WO2008116665A8 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008100621A3 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
12/11/2008WO2008090550A3 Imiquimod production process
12/11/2008WO2008045556A3 Novel synergistic opioid-cannabinoid codrug for pain management
12/11/2008WO2008039640A3 Enantiomeric compounds with antibacterial activity
12/11/2008WO2007110500A8 Use of canthin-6-one and its analogues in the treatment of pathologies linked to mycobacteria
12/11/2008US20080306268 Crystalline clopidogrel hydrobromide and processes for preparation thereof
12/11/2008US20080306266 Process for Preparing 2-Methyl-1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306252 Sulfonamido ether substituted imidazoquinolines
12/11/2008US20080306106 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2008US20080306105 Deuterium-enriched moxifloxacin
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306102 Novel spirooxyindole compounds and drugs containing same
12/11/2008US20080306088 7-chloro-5-(5-piperazin-1-ylmethyl-[1,2,4]oxadiazol-3-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, for the treatment of nervous system disorders and psychological disorders
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306053 Modulation of chemosensory receptors and ligands associated therewith
12/11/2008US20080306048 Therapeutic pyrazoloquinoline urea derivatives
12/11/2008US20080305081 Novel aminopyrimidine derivatives as PLK1 inhibitors
12/11/2008US20080305075 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs
12/11/2008US20080305049 Mri Contrast Agents for Diagnosis and Prognosis of Tumors
12/11/2008US20080303433 Fluorene-based derivative and organic electroluminescence device employing the same
12/11/2008CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008CA2689612A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
12/11/2008CA2689514A1 Heterobicyclic compounds as kinase inhibitors
12/10/2008EP1999130A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors
12/10/2008EP1999129A2 Compounds and methods for inhibiting hepatitis c viral replication
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008EP1999110A2 PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES
12/10/2008EP1998776A2 Pyridine-containing macroheterocylic compounds as kinase inhibitors
12/10/2008EP1998770A1 Use of cantffln-6-one and its analogues in the treatment of pathologies linked to mycobacteria
12/10/2008EP1735312B1 Substituted diaza-spiro-[5.5 -undecane derivatives and their use as neurokinin antagonists
12/10/2008EP1685130B1 Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
12/10/2008EP1675855B1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity
12/10/2008EP1539765B1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321773A Organometallic complex and light-emitting element, light-emitting device and electronic device using the same
12/10/2008CN101321761A Tricyclic amide derivatives useful for treating obesity
12/10/2008CN101321754A New compounds II
12/10/2008CN101321753A Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
12/10/2008CN101321752A 3-amino-2-arylpropyl azaindoles and uses thereof
12/10/2008CN101321751A Met kinase inhibitors
12/10/2008CN101318959A Fine purification preparation process for kuh-seng native
12/10/2008CN101318958A Midbody for preparing spiroindolinepiperidine derivatives
12/10/2008CN101317844A Application of N-methyl-D-asparagic acid acceptor inhibitor in preparing contraceptive medicament
12/10/2008CN100441587C Process for preparing general alooerine
12/10/2008CN100441580C Quinolyl dione derivative and its application in preparing antibiotic medicine
12/10/2008CN100441579C Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
12/10/2008CN100441578C Imidazole ring-containing compound and organic electroluminescence display device
12/10/2008CN100441185C 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
12/09/2008US7462721 Aza-quinolinol phosphonate integrase inhibitor compounds
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462624 Purinone derivatives as HM74a agonists
12/09/2008US7462622 Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/09/2008US7462610 Prostate cancer treatment
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/09/2008CA2382919C Bicyclic imidazo-3-yl-amine derivatives
12/09/2008CA2337804C Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
12/09/2008CA2309051C Sulfamoyl compounds and agricultural and horticultural fungicides
12/04/2008WO2008147547A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008147544A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008146172A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans